Elevated TREM2 mRNA expression in leukocytes in schizophrenia but not major depressive disorder

Journal of Neural Transmission

Volumn 123, Issue 6, 2016, Pages 637-641

  Yoshino, Yuta ^a   Kawabe, Kentaro ^a   Yamazaki, Kiyohiro ^a   Watanabe, Shinya ^b   Numata, Shusuke ^b   Mori, Yoko ^a   Yoshida, Taku ^a   Iga, Junichi ^a   Ohmori, Tetsuro ^b   Ueno, Shu ichi ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Major depressive disorder; Microglia cell; Neuroinflammation; Schizophrenia; TREM2

Indexed keywords

CLOZAPINE; MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; TREM2 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; AGED; BLOOD; METABOLISM; MIDDLE AGED;

AGED; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; LEUKOCYTES; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 84964603330     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-016-1560-3     Document Type: Article

References (24)

1. Airaksinen E, Larsson M, Lundberg I, Forsell Y (2004) Cognitive functions in depressive disorders: evidence from a population-based study. Psychol Med 34(1):83–91
2. Andreasen NC, Nopoulos P, Magnotta V, Pierson R, Ziebell S, Ho BC (2011) Progressive brain change in schizophrenia: a prospective longitudinal study of first-episode schizophrenia. Biol Psychiatry 70(7):672–679
3. Bora E (2015) Neurodevelopmental origin of cognitive impairment in schizophrenia. Psychol Med 45(1):1–9
4. Doorduin J, de Vries EF, Willemsen AT, de Groot JC, Dierckx RA, Klein HC (2009) Neuroinflammation in schizophrenia-related psychosis: a PET study. J Nucl Med 50(11):1801–1807. doi:10.2967/jnumed.109.066647
5. Feigenson KA, Kusnecov AW, Silverstein SM (2014) Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev 38:72–93
6. Furtado M, Katzman MA (2015) Examining the role of neuroinflammation in major depression. Psychiatry Res 229(1–2):27–36
7. Giraldo M, Lopera F, Siniard AL et al (2013) Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer’s disease. Neurobiol Aging 34(8):11–18
8. Guerreiro R, Wojtas A, Bras J et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368(2):117–127
9. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
10. Hickman SE, El Khoury J (2014) TREM2 and the neuroimmunology of Alzheimer’s disease. Biochem Pharmacol 88(4):495–498
11. Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, El Khoury J (2013) The microglial sensome revealed by direct RNA sequencing. Nat Neurosci 16(12):1896–1905
12. Hu N, Tan MS, Yu JT et al (2014) Increased expression of TREM2 in peripheral blood of Alzheimer’s disease patients. J Alzheimers Dis 38(3):497–501
13. Hu W, MacDonald ML, Elswick DE, Sweet RA (2015) The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies. Ann N Y Acad Sci 1338:38–57
14. Inada T (2009) DIEPSS: a second-generation rating scale for antipsychotic-induced extrapyramidal symptoms: drug-induced extrapyramidal symptoms scale. Seiwa Shoten, Tokyo
15. Koth LL, Cambier CJ, Ellwanger A et al (2010) DAP12 is required for macrophage recruitment to the lung in response to cigarette smoke and chemotaxis toward CCL2. J Immunol 184(11):6522–6528
16. Laskaris LE, Di Biase MA, Everall I et al (2015) Microglial activation and progressive brain changes in schizophrenia. Br J Pharmacol 173(4):666–680
17. Lue LF, Schmitz C, Walker DG (2015) What happens to microglial TREM2 in Alzheimer’s disease: immunoregulatory turned into immunopathogenic? Neuroscience 302:138–150
18. Monji A, Kato T, Kanba S (2009) Cytokines and schizophrenia: microglia hypothesis of schizophrenia. Psychiatry Clin Neurosci 63(3):257–265
19. Mori Y, Yoshino Y, Ochi S et al (2015) TREM2 mRNA expression in leukocytes is increased in Alzheimer’s disease and schizophrenia. PLoS One 10(9):e0136835
20. Najjar S, Pearlman (2015) Neuroinflammation and white matter pathology in schizophrenia: systematic review. Schizophr Res 161(1):102–112
21. Rhoades HM, Overall JE (1988) The semistructured BPRS interview and rating guide. Psychopharmacol Bull 24(1):101–104
22. Seeman P, Lee T (1975) Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188(4194):1217–1219
23. Uranova NA, Vikhreva OV, Rachmanova VI, Orlovskaya DD (2011) Ultrastructural alterations of myelinated fibers and oligodendrocytes in the prefrontal cortex in schizophrenia: a postmortem morphometric study. Schizophr Res Treatment 2011:325789. doi:10.1155/2011/325789
24. Yirmiya R, Rimmerman N, Reshef R (2015) Depression as a Microglial Disease. Trends Neurosci 38(10):637–658